$ACHN Recent News U.S. stock futures sink on shutdown

New Post Public Reply Private Reply Replies (0) Message Board

Jan 25, 2014 at 12:52 PM

$ACHN Recent News

U.S. stock futures sink on shutdown fears 7:38 a.m. Sept. 30, 2013 - Barbara Kollmeyer
Zynga shares rise, Achillion drops after hours 4:51 p.m. July 1, 2013 - Wallace Witkowski
FDA puts Achillion Hep C drug on clinical hold 4:16 p.m. July 1, 2013 - MarketWatch.com
Five stocks making moves 2:12 p.m. Feb. 14, 2013 - The Trading Deck
Thursday’s top gaining & declining stocks 4:02 p.m. Sept. 27, 2012 - Greg Morcroft
Achillion sees progress in hepatitis C study 8:04 a.m. Sept. 27, 2012 - MarketWatch.com
Vertex to advance testing of oral HCV drug regimen 9:34 a.m. Sept. 25, 2012 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 3:37 p.m. Sept. 19, 2012 - MarketWatch
Achillion, Idenix move on price target changes 9:29 a.m. Sept. 19, 2012 - Val Brickates Kennedy
Gilead boosted as analysts hike price targets 9:42 a.m. Sept. 17, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 3:47 p.m. Aug. 16, 2012 - MarketWatch
Idenix plunges 30% on HCV drug setback 11:56 a.m. Aug. 16, 2012 - Val Brickates Kennedy
Bristol’s bad news is good for rivals: analysts 4:52 p.m. Aug. 2, 2012 - Val Brickates Kennedy
Gilead shares boosted by Bristol-Myers drug news 10:24 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Bristol-Myers falls 7% on hepatitis C drug setback 9:09 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Stocks to watch Thursday: Annie’s, Rite Aid 4:02 p.m. June 6, 2012 - David B. Wilkerson
Achillion's chief medical officer resigns 3:19 p.m. June 6, 2012 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 3:23 p.m. May 21, 2012 - MarketWatch
Achillion jumps on hepatitis C study 2:22 p.m. May 21, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 4:26 p.m. April 19, 2012 - MarketWatch

Achillion Reports HCV Pipeline Progress and Outlines 2014 HCV Milestones 5:27 a.m. Jan. 13, 2014 - benzinga.com
Achillion Pharmaceuticals (ACHN) Surges: Stock Moves 13.3% Higher - Tale of the Tape 9:04 a.m. Jan. 9, 2014 - Zacks.com
Patients Enrolled in Synageva Study - Analyst Blog 4:15 p.m. Jan. 7, 2014 - Zacks.com
Exelixis (EXEL) Jumps: Stock Moves 11.1% Higher - Tale of the Tape 9:25 a.m. Jan. 7, 2014 - Zacks.com
Athersys (ATHX) in Focus: Stock Moves 6.3% Higher - Tale of the Tape 9:04 a.m. Jan. 7, 2014 - Zacks.com
AxoGen (AXGN) in Focus: Stock Surges 25.0% - Tale of the Tape 9:46 a.m. Jan. 2, 2014 - Zacks.com
Commit To Buy Achillion Pharmaceuticals At $2.50, Earn 24% Using Options 11:08 a.m. Dec. 31, 2013 - TheStreet.com
The Young And Restless Portfolio Update: Heading Into 2014 After A Fabulous 2013 10:07 a.m. Dec. 31, 2013 - Seeking Alpha
Top Insider Trades: SIGM, GBDC, ADC, ACHN 5:05 p.m. Dec. 25, 2013 - TheStreet.com
Good Luck Chasing Celldex 6:00 a.m. Dec. 18, 2013 - TheStreet.com
Agenus (AGEN) Soars: Stock Adds 12.7% in Session - Tale of the Tape 9:04 a.m. Dec. 17, 2013 - Zacks.com
Can Achillion Pharmaceuticals (ACHN) Continue to Surge? - Tale of the Tape 8:55 a.m. Dec. 12, 2013 - Zacks.com
Achillion Pharmaceuticals' CEO Presents at Oppenheimer 24th Annual Healthcare Conference Transcript 6:19 p.m. Dec. 11, 2013 - Seeking Alpha
7 Biotechnology Stocks to Sell Now 4:00 a.m. Dec. 11, 2013 - InvestorPlace.com
Bad News Biotechs Of 2013 7:00 a.m. Dec. 10, 2013 - Seeking Alpha
Achillion Pharmaceuticals, Inc. (ACHN) Shares March Higher, Can It Continue? - Tale of the Tape 7:41 a.m. Dec. 5, 2013 - Zacks.com
Achillion Pharmaceuticals' CEO Presents at 25th Annual Piper Jaffray Healthcare Conference (Transcript) 6:30 p.m. Dec. 4, 2013 - Seeking Alpha
BioDelivery Sciences (BDSI) in Focus: Stock Adds 10.9% in Session - Tale of the Tape 8:37 a.m. Dec. 4, 2013 - Zacks.com
7 Biotechnology Stocks to Sell Now 5:15 a.m. Dec. 4, 2013 - InvestorPlace.com
Benzinga's Top #PreMarket Gainers 7:38 a.m. Dec. 2, 2013 - benzinga.com

Stock Price Movements, FDA Applications, Appointments, and Clinical Study Updates - Research Report on Alere, ARCA, Achillion, Idenix Pharmaceuticals, and Receptos 8:00 a.m. Jan. 13, 2014 - PR Newswire - PRF
Achillion Reports HCV Pipeline Progress and Outlines 2014 HCV Milestones 6:25 a.m. Jan. 13, 2014 - GlobeNewswire
ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ACHN 11:53 a.m. Dec. 6, 2013 - PR Newswire
Increased Quarterly Dividends, HIV Elimination Efforts, Advanced Treatment Options, and Conference Participations - Research Report on Merck, Varian, Mylan, Achillion, and Abiomed 8:00 a.m. Dec. 4, 2013 - PR Newswire
ACHN, CTIC, DRYS and FREE added to NASDAQ Active Stock Watch List at GSR 10:01 a.m. Dec. 2, 2013 - ACCESSWIRE
Achillion to Present at the Three Upcoming Healthcare Conferences 4:05 p.m. Nov. 26, 2013 - GlobeNewswire
ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 1:21 p.m. Nov. 22, 2013 - BusinessWire
SAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Achillion Pharmaceutical, Inc. and Certain Officers - ACLN 8:00 a.m. Nov. 22, 2013 - PR Newswire
Quarterly Reports and Events - Research Report on Mettler-Toledo, Galena Biopharma, Achillion, Wright Medical, and OXiGENE 8:00 a.m. Nov. 15, 2013 - PR Newswire
ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ACHN 3:58 p.m. Nov. 13, 2013 - GlobeNewswire
Achillion Reiterates HCV Pipeline Priorities and Reports Third Quarter and Nine Month 2013 Financial Results 6:05 a.m. Nov. 12, 2013 - GlobeNewswire
Achillion to Present at the Credit Suisse Healthcare Conference 4:05 p.m. Nov. 11, 2013 - GlobeNewswire
SHAREHOLDER ALERT: Investors with More Than $150,000 in Losses from Investments in Achillion Pharmaceuticals, Inc. Are Encouraged to Contact Wolf Haldenstein before the December 9, 2013 Lead Plaintiff Deadline 12:38 p.m. Nov. 7, 2013 - BusinessWire
Achillion's Uridine-Analog Nucleotide Prodrug, ACH-3422, Shows Compelling Preclinical Profile 8:05 a.m. Nov. 2, 2013 - GlobeNewswire
Zeldes Haeggquist & Eck, LLP Announces Investigation of Achillion Pharmaceuticals, Inc. 8:01 a.m. Oct. 31, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Achillion Pharmaceutical, Inc. of Class Action Lawsuit and Upcoming Deadline -- ACLN 1:54 p.m. Oct. 25, 2013 - GlobeNewswire
ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ACHN 10:40 a.m. Oct. 25, 2013 - GlobeNewswire
Wolf Haldenstein Adler Freeman & Herz LLP Commences Class Action Lawsuit on Behalf of Achillion Pharmaceuticals, Inc. Investors 3:12 p.m. Oct. 24, 2013 - BusinessWire
Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Achillion Pharmaceuticals, Inc. 11:05 a.m. Oct. 17, 2013 - PR Newswire
AGNC, ACHN, MNKD and ACAD added to NASDAQ Active Stock Watch List at EPR 8:24 a.m. Oct. 15, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amgen's Board Gains Restaurateur Gibbs Amid Strategic Shift

A Heavyweight Joiner Shakes Up Amgen's Ranks You can almost feel the ground shake when Amgen, a tech giant in biotech, ropes in a high-profile namesake from outside its usual league. David W. Gibbs, the former CEO of Yum! Brands, is now staking his claim at Amgen as a member of its Board of Directors. Effective immediately, Gibbs isn’t just a filler; he's diving...

Brennan Takes a Swing: Barrasso Endorsement in Hand

Brennan Shakes Up Wyoming Politics You don’t need a crystal ball to see the chess game unfolding in Wyoming's political landscape. Shannon Brennan's bid for the House seat in Teton County's District 23 got a heavy artillery boost today. She’s landed the endorsement of Senator John Barrasso, none other than the Senate Majority Whip and a formidable player in the Senate...

Texas Instruments' $2B Notes Fuel Acquisition Ambitions

Pushing Forward with Big Dollars Texas Instruments is setting the stage with an ambitious move by pricing $2.0 billion in investment-grade notes, preparing to shake things up with an acquisition. It's not every day you see a player like TXN dipping into the bond market with such confidence, yet here we are. Four series of senior unsecured notes are slated for issuance on...

Beta Bionics Faces Class Action Over iLet Device Concerns

Securities Fraud Allegations Hit Beta Bionics Here's a fresh one on the market front—Beta Bionics is in hot water, and it's not looking pretty. The ticker NASDAQ:BBNX is swirling in the chaos of a class action lawsuit, thanks to a stock tumble that would make even seasoned traders cringe. What's got investors riled up? The nitty-gritty centers on accusations that the...

PNCC Strengthens Network with Oculeus Anti-Fraud Tech

Palau might not be on everyone's investing radar, but it should be if you're tracking the telecommunication industry in unique locales. The Palau National Communications Corporation (PNCC) has made a strategic move by deploying the Oculeus Anti-Fraud System (AFS) to safeguard its subscribers and commercial operations against the ever-present and sneaky threats of telecom...

ASSA ABLOY Breaks Records in Q3 2026 Report

Another Record Quarter for ASSA ABLOY Well, look who’s breaking records and not just fixing locks. ASSA ABLOY is strutting out of Q3 2026 with numbers worth a double take. The company, based in Stockholm, has reported record sales with a 7% bump, now standing at SEK 40,771 million. Organic growth accounts for a healthy 4%, and if you’re eyeballing where the muscle...

Epic Oceanside Estate Set for No-Reserve Luxury Auction

Going, Going, Gone? A Golf Exec's Dream Home What's hotter than Florida's summer sun? It's this swanky estate at Ponte Vedra Beach set to hit the auction block without any safety net. Yup, no reserve, folks! Leonard "Len" Brown, Jr., the brains behind many of PGA Tour's global ventures, has decided to put his lavish 3.2-acre plot right by the ocean up for grabs. Once...

Workers at CertainTeed Plant Unionize with Teamsters

Unity at CertainTeed Sends Ripples through Industry Here's something that'll stir your coffee: 170 workers at CertainTeed's fiberglass facility in Chowchilla, California, just decided they won't take management's antics lying down. These folks voted to join Teamsters Local 431, aiming for some long-overdue respect and a contract that'll guarantee better wages and...

SLM Hit by Earnings Miss: Shareholders Eye Legal Action

When A Profit Turns To Loss There's a certain sting that comes with expecting a profit only to get smacked with a loss. You know the kind—like when SLM Corporation shareholders had their expectations shattered on October 22, 2026. They figured they'd see a $0.17 profit per share, but what landed instead was a $0.19 loss. That's a $0.36-per-share swing, enough to make...

Kos Biotech Partners Backs Golden Age's Global Push

Unlocking Global Paths for Rare Diseases Diving straight into the biotech hustle, Kos Biotechnology Partners is making waves with their latest strategic move. They've just announced a significant investment in Golden Age Health (GAH), aiming to open new doors for rare disease treatments where they're needed most. Bridging Gaps with Strategic Investment We're talking about...